Press Releases

Poseida Therapeutics Announces Carl June, M.D., to Chair Immuno-Oncology Scientific Advisory Board

March 23, 2021

Poseida Therapeutics Reports Program Updates and Financial Results for the Fourth Quarter and Full Year 2020

March 11, 2021

Poseida Therapeutics Provides Update on Key Programs and Developments During R&D Day

February 24, 2021

Poseida Therapeutics to Host Virtual R&D Day on February 24, 2021

February 10, 2021

Poseida Therapeutics to Participate in Guggenheim Healthcare Talks 2021 Oncology Day

February 4, 2021

Poseida Therapeutics to Participate in SternIR Virtual Corporate Access Event

January 4, 2021

Poseida Therapeutics Added to NASDAQ Biotechnology Index

December 18, 2020

Poseida Therapeutics Appoints Luke Corning to Board of Directors

December 17, 2020

Poseida Therapeutics Provides Update on Phase 1 Trial of P-BCMA-101 at the 2020 American Society of Hematology Annual Meeting

December 5, 2020

Poseida Therapeutics Reports Operational Update and Financial Results for Third Quarter 2020

November 12, 2020